Close

Analyst Ratings for Seres Therapeutics (MCRB)

MCRB Rating Summary

MCRB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MCRB
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.85 (+727.1%) * Over Last 12-Mos
Rating Score: 8 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/26/2023 Oppenheimer
» Updated 1/16/2024
Jeff Jones New Coverage Outperform
(N/A)
9.00
(10.00)
5.46
(1.07)
-80.4% Details
4/21/2023 JPMorgan Tessa Romero New Coverage Neutral
(N/A)
7.00
(N/A)
6.26
(1.07)
-82.91% Details
Like MCRB Ratings? Also take a look at OMGA, MRNA, FHTX, SANA

MCRB Ratings News